Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status-Reference-Cited by-同舟云学术

Docetaxel first-line therapy in HER2-negative advanced breast cancer: a cohort study in patients with prospectively determined HER2 status

Published:2009-11 Issue:10 Volume:20 Page:946-952
ISSN:0959-4973
Container-title:Anti-Cancer Drugs
language:en
Short-container-title:

Author:

Gonçalves Anthony,Deblock Mathilde,Esterni Benjamin,Tarpin Carole,Bertucci François,Gilabert Marine,Charafe-Jauffret Emmanuelle,Jacquemier Jocelyne,Houvenaeghel Gilles,Extra Jean-Marc,Viens Patrice

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology (medical),Pharmacology,Oncology

Reference27 articles.

1. Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial;Nabholtz;J Clin Oncol,2003

2. Docetaxel: a review of its use in metastatic breast cancer;Lyseng-Williamson;Drugs,2005

3. Gene expression patterns of breast carcinomas distinguished tumor subclasses with clinical implications;Sorlie;Proc Natl Acad Sci U S A,2001

4. HER2 as a prognostic factor in breast cancer;Menard;Oncology,2001

5. HER2 overexpression as a prognostic factor in metastatic breast cancer patients treated with high-dose chemotherapy and autologous stem cell support;Guarneri;Bone Marrow Transplant,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of Proteins Responsible for Resistance to Three Chemotherapy Drugs in Breast Cancer Cells Using Proteomics and Bioinformatics Analysis;Molecules;2022-03-08

2. Inhibiting PAD2 enhances the anti-tumor effect of docetaxel in tamoxifen-resistant breast cancer cells;Journal of Experimental & Clinical Cancer Research;2019-10-10

3. Expression of cluster of differentiation 34 and vascular endothelial growth factor in breast cancer, and their prognostic significance;Oncology Letters;2015-06-10

4. Cancer du sein triple-négatif : caractéristiques histocliniques et moléculaires, prise en charge et perspectives thérapeutiques;Bulletin du Cancer;2013-05

5. Inflammatory Breast Cancer: Chemotherapy of Metastatic Disease;Inflammatory Breast Cancer: An Update;2012